{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:19:36Z","timestamp":1779293976097,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109291","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:05:00Z","timestamp":1779293100000},"source":"Crossref","is-referenced-by-count":0,"title":["Lascufloxacin-Induced QT Prolongation in an Elderly Patient Treated With Escitalopram: A Case Report"],"prefix":"10.7759","author":[{"given":"Tetsuro","family":"Koide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hijiri","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1103520","article-title":"Association between corrected QT interval and long-term cardiovascular outcomes in elderly patients who had undergone endovascular therapy for lower extremity arterial disease","volume":"10","author":"Chang YT","year":"2023","unstructured":"Chang YT, Tzeng IS, Jang SJ, et al.. Association between corrected QT interval and long-term cardiovascular outcomes in elderly patients who had undergone endovascular therapy for lower extremity arterial disease. Front Cardiovasc Med. 2023, 10:1103520. 10.3389\/fcvm.2023.1103520","journal-title":"Front Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-022-00341-3","article-title":"Prevalence of drugs and drug combinations that increase risk of prolonged QT time among people with major neurocognitive disorder living in Sweden: a cross-sectional registry study","volume":"10","author":"Gustafsson M","year":"2023","unstructured":"Gustafsson M, Altufaili M, Sj\u00f6lander M. Prevalence of drugs and drug combinations that increase risk of prolonged QT time among people with major neurocognitive disorder living in Sweden: a cross-sectional registry study. Drugs Real World Outcomes. 2023, 10:61-8. 10.1007\/s40801-022-00341-3","journal-title":"Drugs Real World Outcomes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2024.01.003","article-title":"Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: a single-arm, open-label clinical trial","volume":"30","author":"Takazono T","year":"2024","unstructured":"Takazono T, Hosogaya N, Fukushima K, et al.. Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: a single-arm, open-label clinical trial. J Infect Chemother. 2024, 30:597-602. 10.1016\/j.jiac.2024.01.003","journal-title":"J Infect Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000334441","article-title":"QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications","volume":"120","author":"Briasoulis A","year":"2011","unstructured":"Briasoulis A, Agarwal V, Pierce WJ. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications. Cardiology. 2011, 120:103-10. 10.1159\/000334441","journal-title":"Cardiology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70263","article-title":"Large-scale analysis of age and sex effects on corrected QT and JT intervals: insights from hospital-based controls and moxifloxacin-treated cases","volume":"18","author":"Kim E","year":"2025","unstructured":"Kim E, Lee HY, Ye YM, Kim A. Large-scale analysis of age and sex effects on corrected QT and JT intervals: insights from hospital-based controls and moxifloxacin-treated cases. Clin Transl Sci. 2025, 18:e70263. 10.1111\/cts.70263","journal-title":"Clin Transl Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2025.104384","article-title":"Cognitive behavioral therapy combined with escitalopram in the treatment of senile depression","volume":"107","author":"Wen A","year":"2025","unstructured":"Wen A, Wei Z, Zhang S, Ma J, Zhang Y, Li Y, Zhang Y. Cognitive behavioral therapy combined with escitalopram in the treatment of senile depression. Asian J Psychiatr. 2025, 107:104384. 10.1016\/j.ajp.2025.104384","journal-title":"Asian J Psychiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4685-7","article-title":"A comparative study of QT prolongation with serotonin reuptake inhibitors","volume":"234","author":"Ojero-Senard A","year":"2017","unstructured":"Ojero-Senard A, Benevent J, Bondon-Guitton E, et al.. A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology (Berl). 2017, 234:3075-81. 10.1007\/s00213-017-4685-7","journal-title":"Psychopharmacology (Berl)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03569-y","article-title":"Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial","volume":"31","author":"Rajji TK","year":"2025","unstructured":"Rajji TK, Baksh SN, Shade DM, et al.. Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial. Nat Med. 2025, 31:1586-91. 10.1038\/s41591-025-03569-y","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030804","article-title":"Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?","volume":"15","author":"Rusu A","year":"2023","unstructured":"Rusu A, Munteanu AC, Arb\u0103na\u0219i EM, Uivarosi V. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?. Pharmaceutics. 2023, 15:30804. 10.3390\/pharmaceutics15030804","journal-title":"Pharmaceutics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1573403x12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu LX","year":"2016","unstructured":"Cubeddu LX. Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias. Curr Cardiol Rev. 2016, 12:141-54. 10.2174\/1573403x12666160301120217","journal-title":"Curr Cardiol Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1715163516641136","article-title":"Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management","volume":"149","author":"Tisdale JE","year":"2016","unstructured":"Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016, 149:139-52. 10.1177\/1715163516641136","journal-title":"Can Pharm J (Ott)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk KA","year":"2013","unstructured":"Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Ann Pharmacother. 2013, 47:1330-41. 10.1177\/1060028013501994","journal-title":"Ann Pharmacother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5770\/cgj.28.835","article-title":"A description of QT-interval prolonging drug interactions with fluoroquinolones in older women with uncomplicated urinary tract infections","volume":"28","author":"Trenaman SC","year":"2025","unstructured":"Trenaman SC, von Maltzahn M, Stewart SA, Tamim H, Sketris I, Black E. A description of QT-interval prolonging drug interactions with fluoroquinolones in older women with uncomplicated urinary tract infections. Can Geriatr J. 2025, 28:228-34. 10.5770\/cgj.28.835","journal-title":"Can Geriatr J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1060_20","article-title":"Top 20 drug - drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients","volume":"9","author":"Das B","year":"2020","unstructured":"Das B, Ramasubbu SK, Kumar B, Rawat VS. Top 20 drug - drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients. J Family Med Prim Care. 2020, 9:6023-40. 10.4103\/jfmpc.jfmpc_1060_20","journal-title":"J Family Med Prim Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn JR","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007, 41:674-80. 10.1345\/aph.1H423","journal-title":"Ann Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492284-lascufloxacin-induced-qt-prolongation-in-an-elderly-patient-treated-with-escitalopram-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:05:00Z","timestamp":1779293100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492284-lascufloxacin-induced-qt-prolongation-in-an-elderly-patient-treated-with-escitalopram-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.109291","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}